Interviews

Dr Richard Snyder Offers Key Features of Value-Based Agreements
December 04, 2019 – 
Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses key features that payers should include when implementing a value-based agreement.
Dr Richard Snyder Discusses the Role of Data in Value-Based Agreements
November 23, 2019 – 
Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses the role of data exchange and analytics in value-based agreements.
Dr Richard Snyder Emphasizes the Importance of Care Coordination in Value-Based Contracting
November 10, 2019 – 
Population health management and coordination of care are integral to value-based contracting, explained Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross.
Dr Richard Snyder: How Value-Based Agreements Can Benefit All Stakeholders
October 27, 2019 – 
Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, explains how value-based agreements can benefit providers, patients, and payers.
Dr Richard Snyder on the Impact of Novel, Costly Drugs on Prevalence of Value-Based Agreements
October 15, 2019 – 
Richard Snyder, MD, executive vice president of Facilitated Health Networks and chief medical officer at Independence Blue Cross, discusses how the increasing share of novel, costly therapies will impact the prevalence of value-based agreements.
Terrill Jordan Reflects on Practice Transformation Under OCM
October 11, 2019 – 
The main thing that the Oncology Care Model (OCM) has brought is a shift in the mindset, said Terrill Jordan, chief executive officer of Regional Cancer Care Associates.
Dr Lawrence Shulman Discusses the Role of Rising Drug Costs in Value-Based Care
October 06, 2019 – 
Lawrence N. Shulman, MD, director of the Center for Global Cancer Medicine at the Abramson Cancer Center, and professor of Medicine at the Hospital of the University of Pennsylvania, explains how providers are reacting to more effective, more costly therapies entering the cancer landscape.
Terrill Jordan Discusses OCM Performance Period 4 Results
October 01, 2019 – 
Terrill Jordan, chief executive officer of Regional Cancer Care Associates, discusses Oncology Care Model performance period 4 results and the biggest challenges community oncologists continue to face when trying to perform under the model.
Dr Michael Kolodziej Discusses Taking on 2-Sided Risk in OCM After PP4 Results
September 26, 2019 – 
Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc., discusses the move to 2-sided risk in the Oncology Care Model (OCM).
Dr Blase Polite Outlines the Decision to Move to 2-Sided Risk in the OCM
September 22, 2019 – 
CMS is trying to make a 2-sided risk model in the Oncology Care Model enticing for practices, but there is still a lot of math practices need to work out before making the decision, said Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.